Practical Strategies for Determining the Duration of Anticoagulation in Patients Diagnosed with VTE
Practical Strategies for Determining the Duration of Anticoagulation in Patients Diagnosed with VTE CME, CNE, CE Jori May, MD; Stephan Moll, MD; and Paul Lewis, MD, FAAFP, ABPM-CI, CPE, CPHIMS |
||
Release Date: April 26, 2024 Expiration Date: April 26, 2025 |
||
In this accredited activity, a panel of experts in hematology/VTE and primary care address the critical question of the duration of anticoagulation in a patient who has experienced a DVT or PE. Faculty will outline the factors that will guide the nonspecialist in determining a patient’s risk of recurrence and identifying whether the patient should undergo anticoagulation of short- or long-term duration. Through the use of tools that consider not only the patient’s current and ongoing risk factors, but that provide guidance on which patients should receive D-dimer or thrombophilia testing, participants will increase their ability to answer questions that include, “Is my patient at risk for recurrence of their VTE?”, “Should I use a D-dimer test or test the patient for thrombophilia?” and “Once I have the test results, do I know what to do with them?” Provided by MediCom Worldwide, Inc.This activity is supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance. |
||
Begin, Earn CreditView Only, No Credit | ||